Ph Baptist Easley Hospital
- Type
- Teaching hospital
- Where
- Easley, SC
- Medicare CCN
- 420015
- Received
- $1,040,085 in 142 records, 2022 ($59,915 general, $980,170 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2022 | General payment | 17 | $59,915 |
| 2022 | Research payment | 125 | $980,170 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ENDOTRONIX, INC. | 1 | $703,280 | 2022 |
| AstraZeneca Pharmaceuticals LP | 6 | $117,361 | 2022 |
| Philips North America LLC | 3 | $34,422 | 2022 |
| Smith+Nephew, Inc. | 3 | $32,222 | 2022 |
| AstraZeneca UK Limited | 3 | $30,484 | 2022 |
| ZOLL Circulation Inc | 2 | $27,800 | 2022 |
| ABBVIE INC. | 8 | $27,298 | 2022 |
| INSTYLLA, INC. | 1 | $10,650 | 2022 |
| Abbott Laboratories | 8 | $10,360 | 2022 |
| Contego Medical, Inc | 6 | $9,635 | 2022 |
| Novo Nordisk AS | 82 | $7,440 | 2022 |
| Boston Scientific Corporation | 5 | $7,085 | 2022 |
| AngioDynamics, Inc. | 1 | $6,583 | 2022 |
| Cook Medical LLC | 3 | $4,600 | 2022 |
| Siemens Medical Solutions USA, Inc. | 1 | $2,500 | 2022 |
| Medical Device Business Services, Inc. | 1 | $2,000 | 2022 |
| Acerta Pharma LLC | 3 | $1,842 | 2022 |
| Alexion Pharmaceuticals, Inc. | 1 | $1,500 | 2022 |
| BeiGene, Ltd. | 1 | $1,000 | 2022 |
| ZOLL Medical Corporation | 1 | $1,000 | 2022 |
| Stryker Corporation | 1 | $709 | 2022 |
| Janssen Research & Development, LLC | 1 | $311 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 125 | $980,170 |
| Grant | 7 | $39,122 |
| Long term medical supply or device loan | 2 | $7,292 |
| Space rental or facility fees (teaching hospital only) | 4 | $4,900 |
| Charitable Contribution | 3 | $4,600 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $4,000 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | ENDOTRONIX, INC. | $703,280 | Research payment | Cash or cash equivalent | CORDELLA PULOMONARY ARTERY PRESSURE SENSOR Device, HEART FAILURE | PROACTIVE-HF | 2022 |
| 2022-12-31 | AngioDynamics, Inc. | $6,583 | Long term medical supply or device loan | In-kind items and services | Auryon Laser System 100-120 Vac Device, ET | 2022 | |
| 2022-12-31 | AstraZeneca Pharmaceuticals LP | $1,236 | Research payment | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | REALIZE-K Phase IV, randomized, double-blind, placebo-controlled, parallel-group trial evaluating Sodium Zirconium Cyclo | 2022 |
| 2022-12-31 | ABBVIE INC. | $1,235 | Research payment | In-kind items and services | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-12-31 | Stryker Corporation | $709 | Long term medical supply or device loan | In-kind items and services | PRIME SERIES Device, PATIENT HANDLING - PH | 2022 | |
| 2022-12-31 | AstraZeneca UK Limited | $682 | Research payment | In-kind items and services | LOKELMA Drug, Cardiovascular and Metabolism | REALIZE-K Phase IV, randomized, double-blind, placebo-controlled, parallel-group trial evaluating Sodium Zirconium Cyclo | 2022 |
| 2022-12-31 | Acerta Pharma LLC | $35 | Research payment | In-kind items and services | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2022 |
| 2022-12-16 | Philips North America LLC | $12,518 | Research payment | Cash or cash equivalent | (9532) PD Other Device, Medical Device | Lung AI - GHL Study | 2022 |
| 2022-12-01 | ABBVIE INC. | $472 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-11-30 | Medical Device Business Services, Inc. | $2,000 | Grant | Cash or cash equivalent | VICRYL Device, Sutures | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-18 | Novo Nordisk AS | $11 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-11-09 | Abbott Laboratories | $3,370 | Research payment | Cash or cash equivalent | DRAGONFLY OPSTAR Device, Vascular | Optical Coherence Tomography Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized Trial | 2022 |
| 2022-11-09 | ABBVIE INC. | $2,812 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-10-26 | Abbott Laboratories | $1,165 | Research payment | Cash or cash equivalent | Device, Vascular | Abbott Next Generation Drug Eluting Stent 48mm Study (SPIRIT 48) | 2022 |
| 2022-10-18 | Siemens Medical Solutions USA, Inc. | $2,500 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-10-12 | ABBVIE INC. | $3,284 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-09-30 | Cook Medical LLC | $2,625 | Charitable Contribution | In-kind items and services | HIWIRE Device, WIRE GUIDES | 2022 | |
| 2022-09-30 | Cook Medical LLC | $1,749 | Charitable Contribution | In-kind items and services | CXI Device, SPECIALTY CATHETERS | 2022 | |
| 2022-09-30 | Novo Nordisk AS | $607 | Research payment | Cash or cash equivalent | NN7415-4807 | 2022 | |
| 2022-09-30 | Cook Medical LLC | $225 | Charitable Contribution | In-kind items and services | BENTSON Device, WIRE GUIDES | 2022 | |
| 2022-09-27 | ZOLL Circulation Inc | $400 | Research payment | Cash or cash equivalent | TherOx DS2 Console Device, TherOx Therapy | ISOSHOCK | 2022 |
| 2022-09-22 | Abbott Laboratories | $2,025 | Research payment | Cash or cash equivalent | DRAGONFLY OPSTAR Device, Vascular | Validation of OCT-based FUSION Study | 2022 |
| 2022-09-22 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | DRAGONFLY OPSTAR Device, Vascular | Validation of OCT-based FUSION Study | 2022 |
| 2022-09-14 | AstraZeneca Pharmaceuticals LP | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ANDEXXA Biological, Rare Disease | 2022 | |
| 2022-09-09 | Contego Medical, Inc | $1,250 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-08 | Novo Nordisk AS | $9 | Research payment | In-kind items and services | NN7415-4807 | 2022 | |
| 2022-09-06 | Boston Scientific Corporation | $435 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | RANGER II SFA | 2022 |
| 2022-08-18 | AstraZeneca UK Limited | $29,280 | Research payment | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | REALIZE-K Phase IV, randomized, double-blind, placebo-controlled, parallel-group trial evaluating Sodium Zirconium Cyclo | 2022 |
| 2022-08-17 | Abbott Laboratories | $1,665 | Research payment | Cash or cash equivalent | DRAGONFLY OPSTAR Device, Vascular | Optical Coherence Tomography Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized Trial | 2022 |
| 2022-08-10 | Abbott Laboratories | $1,005 | Research payment | Cash or cash equivalent | Device, Vascular | Abbott Next Generation Drug Eluting Stent 48mm Study (SPIRIT 48) | 2022 |
| 2022-08-08 | Smith+Nephew, Inc. | $14,025 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-08-08 | Smith+Nephew, Inc. | $12,332 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-08-08 | Smith+Nephew, Inc. | $5,863 | Grant | Cash or cash equivalent | 2022 | ||
| 2022-07-21 | Abbott Laboratories | $80 | Research payment | In-kind items and services | Xience SkyPoint Device, Vascular | XIENCE Skypoint Large Vessel Post Approval Study (SPIRIT XLV PAS) | 2022 |
| 2022-07-21 | Abbott Laboratories | $50 | Research payment | In-kind items and services | Xience SkyPoint Device, Vascular | XIENCE Skypoint Large Vessel Post Approval Study (SPIRIT XLV PAS) | 2022 |
| 2022-07-07 | ABBVIE INC. | $472 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-06-13 | ZOLL Medical Corporation | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, DEFIBRILLATOR | 2022 | |
| 2022-06-06 | Boston Scientific Corporation | $250 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | RANGER II SFA | 2022 |
| 2022-05-27 | Janssen Research & Development, LLC | $311 | Research payment | Cash or cash equivalent | ERLEADA Drug, Oncology | A Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locall | 2022 |
| 2022-05-17 | Contego Medical, Inc | $1,250 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-05-12 | ABBVIE INC. | $6,569 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-05-12 | Contego Medical, Inc | $2,080 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-04-26 | Philips North America LLC | $3,800 | Research payment | Cash or cash equivalent | (9532) PD Other Device, Medical Device | B-Line Detection Project | 2022 |
| 2022-04-22 | Contego Medical, Inc | $1,250 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-04-15 | AstraZeneca Pharmaceuticals LP | $9,350 | Research payment | Cash or cash equivalent | SERENA 4 A Randomised Multicentre Double Blind Phase 3 Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastraz | 2022 | |
| 2022-04-04 | Philips North America LLC | $18,104 | Research payment | Cash or cash equivalent | (9532) PD Other Device, Medical Device | Lung AI GHL Study | 2022 |
| 2022-03-28 | Novo Nordisk AS | $2,989 | Research payment | Cash or cash equivalent | NN7415-4807 | 2022 | |
| 2022-03-25 | BeiGene, Ltd. | $1,000 | Research payment | Cash or cash equivalent | BRUKINSA Drug, Oncology | A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) Plus Rituximab Versus Bendamustine | 2022 |
| 2022-03-21 | AstraZeneca Pharmaceuticals LP | $53,055 | Research payment | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | REALIZE-K Phase IV, randomized, double-blind, placebo-controlled, parallel-group trial evaluating Sodium Zirconium Cyclo | 2022 |
| 2022-03-17 | Acerta Pharma LLC | $1,000 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | Part 1 FL An Open label Phase 1b Study of ACP196 Alone or in Combination with Rituximab in Subjects with Follicular Lym | 2022 |
| 2022-03-15 | Boston Scientific Corporation | $900 | Grant | Cash or cash equivalent | GENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART | 2022 | |
| 2022-03-01 | AstraZeneca UK Limited | $522 | Research payment | Cash or cash equivalent | IMFINZI Biological, Oncology | An Open-Label Multi-Center Global Study to Evaluate Long Term Safety and Efficacy in Patients Who Are Receiving or who P | 2022 |
| 2022-02-25 | Contego Medical, Inc | $360 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-02-18 | Contego Medical, Inc | $3,445 | Research payment | Cash or cash equivalent | Neuroguard IEP Device, Cardiovascular | Performance II | 2022 |
| 2022-02-16 | AstraZeneca Pharmaceuticals LP | $51,320 | Research payment | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | Dapagliflozin in Acute Decompensated Heart Failure | 2022 |
| 2022-02-16 | Novo Nordisk AS | $2,000 | Research payment | Cash or cash equivalent | NN7415-4807 | 2022 | |
| 2022-02-16 | Novo Nordisk AS | $1,000 | Research payment | Cash or cash equivalent | NN7415-4807 | 2022 | |
| 2022-02-14 | AstraZeneca Pharmaceuticals LP | $900 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BRILINTA Drug, Cardiovascular and Metabolism | 2022 | |
| 2022-02-10 | ZOLL Circulation Inc | $27,400 | Research payment | Cash or cash equivalent | TherOx DS2 Console Device, TherOx Therapy | ISOSHOCK | 2022 |
| 2022-02-08 | ABBVIE INC. | $2,449 | Research payment | Cash or cash equivalent | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In | 2022 | |
| 2022-02-08 | Boston Scientific Corporation | $1,500 | Grant | Cash or cash equivalent | General - Structural Heart Device, STRUCTURAL HEART | 2022 | |
| 2022-02-03 | Alexion Pharmaceuticals, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ANDEXXA Biological, Rare Disease | 2022 | |
| 2022-02-01 | ABBVIE INC. | $10,000 | Research payment | Cash or cash equivalent | VENCLEXTA Drug, ONCOLOGY | Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It | 2022 |
| 2022-01-10 | INSTYLLA, INC. | $10,650 | Research payment | Cash or cash equivalent | INSTYLLA MICROCATHETER Device, Liquid Embolics for Interventional Radiology | Randomized Multi-Center, Subject and Evaluator Blinded, Parallel-Group Study to Evaluate the Safety and Effectiveness of | 2022 |
| 2022-01-07 | Acerta Pharma LLC | $807 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreat | 2022 |
| 2022-01-04 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | GENERAL - THERAPIES Device, THERAPIES | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Easley, SC, county Pickens County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Easley, SC | County Pickens County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 24,841 | 134,629 | 5,296,225 |
| Population, 2020 census P1 | 22,921 | 131,404 | 5,118,425 |
| Median age B01002 | 39.2 | 36.2 | 40.2 |
| Under 18 B01001 | 20.3% | 18.6% | 21.4% |
| 65 and over B01001 | 20.2% | 17.3% | 18.9% |
| Households B11001 | 10,949 | 52,414 | 2,117,989 |
| Foreign born B05002 | 5.1% | 3.5% | 5.8% |
| Median household income B19013 | $66,299 | $61,064 | $69,324 |
| Median family income B19113 | $85,136 | $82,277 | $86,707 |
| Per capita income B19301 | $47,218 | $34,724 | $39,236 |
| Poverty rate B17001 | 13.9% | 17.2% | 14.1% |
| Unemployment rate B23025 | 3.2% | 3.6% | 4.9% |
| Civilian labor force B23025 | 12,110 | 64,155 | 2,560,429 |
| Mean commute (minutes) B08013 | 27.0 | 26.4 | 25.6 |
| Bachelor's degree or higher B15003 | 31.9% | 28.5% | 32.1% |
| Housing units B25001 | 11,898 | 58,677 | 2,443,039 |
| Owner-occupied B25003 | 68.9% | 70.9% | 71.9% |
| Renters B25003 | 31.1% | 29.1% | 28.1% |
| Median home value B25077 | $263,500 | $231,900 | $259,000 |
| Median gross rent B25064 | $947 | $972 | $1,180 |
| White, not Hispanic B03002 | 77.9% | 82.7% | 61.9% |
| Black B03002 | 7.4% | 5.7% | 24.6% |
| Hispanic or Latino B03002 | 10.0% | 5.4% | 7.4% |
| Asian B03002 | 0.6% | 1.6% | 1.7% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Easley, SC.
Comments